Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
The American Journal of Cardiology|February 1, 1986
Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trialP E Pool, B M Massie, K Venkataraman, et al.Circulation|August 10, 2000
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trialB F Uretsky, K Thygesen, P W Armstrong, et al.Journal of the American College of Cardiology|July 1, 1985
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failureM A Creager, B M Massie, D P Faxon, et al.Anaesthesia|October 14, 2004
Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damageB W Böttiger, J Motsch, P Teschendorf, et al.The Journal of Thoracic and Cardiovascular Surgery|October 1, 1994
Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularizationH A Hennein, H Ebba, J L Rodriguez, et al.The Journal of Thoracic and Cardiovascular Surgery|September 10, 1998
Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research GroupB D Spiess, C Ley, S C Body, et al.The New England Journal of Medicine|April 1, 1993
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsB J Materson, D J Reda, W C Cushman, et al.The Journal of Clinical Investigation|September 1, 1990
Skeletal muscle response to exercise training in congestive heart failureJ R Minotti, E C Johnson, T L Hudson, et al.Circulation|August 1, 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)B M Massie, M R Berk, S C Brozena, et al.Archives of Internal Medicine|September 11, 1995
Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsB J Materson, D J Reda, R A Preston, et al.Pageof 23